Trending

Layoff News > Healthcare > Arvinas

Arvinas Layoffs 2026: 15% Workforce Cut Tied to Vepdegestrant Strategy Shift

Published Sep 16, 2025

45
Employees Affected
15%
Percentage

Connecticut-based biotech Arvinas is cutting about 15% of its workforce, primarily in roles linked to vepdegestrant commercialization, after choosing a third-party developer for its Pfizer-partnered estrogen receptor degrader. Layoffs are expected to finish in Q1 2026

More From Layoff.Today